Reuters
Regulators say data on the risks are murky, and they are looking to the panel of outside medical experts to help make sense of findings from 23 clinical trials of nine different drugs.
U.S. Food and Drug Administration (news - web sites) officials said they are being careful because they do not want to unnecessarily discourage doctors from prescribing the drugs for depression, a serious mental illness that itself raises suicide risk.
More...
|